Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Apply
Ficerafusp Alfa & Pembrolizumab
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step